Literature DB >> 33323694

Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19.

A Taylor Kelley1, Matthew T Dungan, Adam J Gordon.   

Abstract

Entities:  

Year:  2020        PMID: 33323694     DOI: 10.1097/ADM.0000000000000786

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


× No keyword cloud information.
  3 in total

1.  Aligning quality improvement efforts and policy goals in a national integrated health system.

Authors:  Melissa Z Braganza; Elsa Pearson; Cecille Joan Avila; Dave Zlowe; John Øvretveit; Amy M Kilbourne
Journal:  Health Serv Res       Date:  2022-03-04       Impact factor: 3.734

2.  Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force report.

Authors:  Paul J Joudrey; Gavin Bart; Robert K Brooner; Lawrence Brown; Julie Dickson-Gomez; Adam Gordon; Sarah S Kawasaki; Jane M Liebschutz; Edward Nunes; Dennis McCarty; Robert P Schwartz; José Szapocnik; Madhukar Trivedi; Judith I Tsui; Arthur Williams; Li-Tzy Wu; David A Fiellin
Journal:  Subst Abus       Date:  2021       Impact factor: 3.716

3.  It will end in tiers: A strategy to include "dabblers" in the buprenorphine workforce after the X-waiver.

Authors:  Brendan Saloner; Barbara Andraka Christou; Adam J Gordon; Bradley D Stein
Journal:  Subst Abus       Date:  2021-04-02       Impact factor: 3.716

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.